Plant Disease Diagnostics Market
Global Market Study on Plant Disease Diagnostics: Agricultural Laboratories to Drive Market Expansion
Plant Disease Diagnostics Market Segmented By Kits, Lateral Flow Devices, DNA/RNA Probes, Accessories, Consumables Software and Cloud Databases Product with Molecular Tests, Serological Tests, Tests Using Electronic Technology
The global plant disease diagnostics market was valued at US$ 88.8 Mn in 2020, and is expected to register a CAGR of 4.2% over the forecast period (2021-2031). As per Persistence Market Research’s projections, serological tests hold a substantial share of 57.2% in the overall market.
Find Out More about the Report Coverage
- Thermo Fisher Scientific Inc.
- ClearDetections B.V.
- Merck KGaA
- Agdia, Inc.
- Qualiplante SAS
- LOEWE Biochemica GmbH
- BIOREBA AG
- Agrisera AB
- Biosense Laboratories AS
- OptiGene Limited
- TwistDx Limited
Key Insights Covered in Plant Disease Diagnostics Industry Survey:
- Market Estimates and Forecasts (2016-2031)
- Key Drivers and Restraints Shaping Market Growth
- Segment-wise, Country-wise, and Region-wise Analysis
- Competition Mapping and Benchmarking
- Market Share Analysis By Key Players
- Key Product Innovations and Regulatory Climate
- COVID-19 Impact on Demand for Plant Disease Diagnostics and How to Navigate
- Recommendation on Key Winning Strategies
Customize this Report
Explore Intelligence Tailored to Your Business Goals.
Sales Analysis of Plant Disease Diagnostic Products from 2016 to 2020 Vs. Market Outlook for 2021 to 2031
The plant disease diagnostics market was valued at US$ 88.8 Mn in 2020. Climate change severely impacted plant disease diagnostics by affecting agricultural production through its effects on the timing, intensity, and variability of rainfall, and shifts in temperatures and carbon dioxide concentrations.
Plant diseases are likely to become more severe, epidemics will be more frequent, and some pathogens will spread to new areas. Agricultural research must respond to these predicted changes. It also highlights the uncertainties as to where, when, and if plant diseases will become more severe, causing greater crop losses and threatening future food production, particularly in the latter half of this century.
Increased adoption of advanced biotechnology methods, forest plantation, and app-based products have led to an increase the demand for plant disease diagnostics.
The global market expected to register a CAGR of 4.2% during the forecast period (2021-2031).
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
What Opportunities Await Plant Disease Diagnostic Product Manufacturers?
With changing technology and advancements in agriculture research, cultivators are becoming more aware about the advanced technologies to increase yield. Furthermore, farmers are being educated to identify plant disease symptoms at an early stage to avoid destruction of entire crops and the spread of plant diseases.
This increased demand opportunity is identified by a number of service providers, and some of them have developed their own detection and diagnosis methods; most use readily available diagnostic kits. Furthermore, service providers also work toward developing partnerships with software companies for growth of product business
With increase in agriculture R&D and development of new and more advanced diagnostic methods, more growth opportunities for plant disease diagnostics providers will be created. Although new technologies are yet being researched and assessed, they are expected to be launched into the market soon.
Thus, demand for organic food, advancements in research & development, and growing role of the private sector provide an array of opportunities for emerging as well as established players to mark their presence in the global market.
Explore Persistence Market Research’s expertise in promulgation of the business !
Which Factors Restraining Demand for Plant Disease Diagnostics?
Increasing consumption of pesticides have shown to lower the chance of pathogenic infections in plants. Consumers assume that plant disease testing is unnecessary, and in particular, early detection testing is omitted by cultivators. Thus, continued use of pesticides despite the efforts to reduce their consumption will hamper market growth to some extent.
Quantitative PCR is a highly available and effective method when symptoms are present; it is widely applied to confirm diagnosis after symptoms appear. Decreasing costs of kits, reagents, and equipment render them available for use by large companies or consortia who can afford a molecular biology lab.
However, like ELISA, these methods are time consuming; several days are required to extract RNA, perform RNA qualitative analysis, synthesize cDNA, amplify it, and analyze the resulting data. Furthermore, it is also unable to detect early infections and is quite unreliable before the symptoms appear.
Most products require skilled personnel to conduct diagnostic testing and assess the results. Although there are a few plant disease diagnostic methods that are easy to conduct, their lack of availability, high cost of devices, unreliable results, and difficulty in analyzing results have resulted in slow adoption.
Development of biotechnology methods such as GM plants and tissue culture plants could lead to decreased use of genetic diagnostic testing methods, thereby hindering the growth of the market for plant disease diagnostics.
What Makes the U.S. the Largest Market for Plant Disease Diagnostics?
The U.S. dominates the North American region with a market share of 91.8%, and is projected to continue experiencing high growth throughout the forecast period.
Market growth in is due to rising research & development activities, systematic diagnostic laboratories, strong presence of key market players, and high adoption of advanced assay technologies.
Why is Spain Considered a Lucrative Market for Plant Disease Diagnostics in Europe?
Spain dominates the European market for plant disease diagnostic with a share of 20.6%. Growth of the market is driven by rising trend of genetic engineering and plant genomic research, and this is resulting in high share of the country in the market for plant disease diagnostics in the region
Additionally, large number of service providers are entering into research collaborations to develop effective solutions for plant disease diagnostics.
- For instance, in June 2021, Agdia Inc. released the rapid molecular assay for the detection of fungal pathogen causing panama diseases in bananas.
What Makes China an Emerging Market for Plant Disease Diagnostics?
China holds 47.6% share in the East Asia market, and is projected to expand at a CAGR of 5.2% through 2031.
Advancements in plant disease diagnosis technology and key players focused on entering into global strategic alliances with leading companies providing pathogen diagnostic testing services are factors attributed to the growth of the market in the country.
Which Plant Disease Diagnostic Product is Driving Market Growth?
In terms of product, kits hold around 42.1% market value share globally. Segment growth is primarily attributed to advancements in technology and developments in molecular diagnostic methods globally.
Why are Tests Highly Preferred for Plant Disease Diagnostics?
The serological test segment is leading with 57.2% market share. Specificity and accuracy in results and low sample requirements are positively driving demand for plant disease diagnostics.
Which Sample is Most Preferred for Plant Disease Diagnostics?
Plants are estimated to dominate the market by sample. This segment accounted for approximately 39% share of the market in 2021, owing massive number of diseases associated with plants, and hence, they are employed as a sample in several diagnostic procedures.
What is the Impact of Market Consolidation on This Space?
Considering consolation activities in the global market, mergers and acquisitions have emerged as one of the key growth strategies by market players. Prominent players are strengthening their product ranges through acquisitions and reaching out to key as well as emerging markets.
- In November 2020, Merck and Siemens announced a collaborative agreement for the digitization of manufacturing. Merck's partnership aims to extend the notion of flexible and simple interlinking of individual modules across the company's whole process development and production network.
- In March 2020, Agdia Inc. released immunostrip for the detection of fire blight pathogens on apples and pears.
Key players are focusing on expansion in emerging regions and new revised product manufacturing. The strategy of expansion, new product launches, approvals, agreements, partnerships, collaborations, and developed distribution channels such as online sales by key manufacturers is further strengthening their market presence.
- In January 2021, Merck acquired AmpTec to expand mRNA capabilities of vaccines, treatment, and diagnostics. Merck's ability to design and produce mRNA for use in vaccines, therapies, and diagnostics of COVID-19 and other diseases has been strengthened as a result of the deal.
- In May 2020, Agdia Inc. released rapid molecular assays for detection of phytoplasmas causing Grapevine Yellows disease.
Similarly, recent developments related to companies manufacturing plant disease diagnostic products have been tracked by the team at Persistence Market Research, which are available in the full report.
Report Scope as per Plant Disease Diagnostics Industry Analysis
Historical Data Available for
US$ Mn for Value
Key Regions Covered
Key Countries Covered
Key Market Segments Covered
Key Companies Profiled
Available upon Request
Key Segments Covered in Plant Disease Diagnostics Industry Research
- Elisa Kits
- DNA-based Diagnostics Kits
- Protein-based Diagnostics Kits
- Lateral Flow Devices
- DNA/RNA Probes
- Accessories and Other Consumables
- Software and Cloud Databases
- Molecular Tests
- PCR-based Assays
- PCR & RT-PCR
- Multiplex PCR
- Isothermal Amplification Assays
- Microarray Assays
- The LAMP Assays
- PCR-based Assays
- Serological Tests
- Tests Using Electronic Technology
By End User
- Agricultural Laboratories
- Academic and Research Institutes
- Food Processing Laboratories
- Contract Research Organizations
Enquiry before Buying
- Is the market research conducted by Persistence Market Research?
Yes, the report filled with acne treatment market insights has been compiled by expert analysts of Persistence Market Research, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
- What research methodology is followed by Persistence Market Research?
Persistence Market Research follows a methodology that encompasses the demand-side assessment and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
- Who are the respondents for primary research?
Persistence Market Research speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
- What are the sources of secondary research?
Persistence Market Research conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
- Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through email.
- How can I buy this report?
Persistence Market Research provides a secure online payment system to buy reports seamlessly. You can buy the report securely and safely.